Month: June 2021
BOCA RATON, FL, June 29, 2021 (GLOBE NEWSWIRE) — Stem Holdings, Inc. d/b/a Driven by Stem (OTCQX: STMH) (CSE: STEM) (the “Company” or “Stem“), the first multi-state, vertically integrated Farm-to-Home™ (F2H) cultivation and technology omnichannel cannabis company featuring a proprietary Delivery-as-a-Service (DaaS) marketplace platform, today announced the availability of its virtual road show presentation on ChannelChek, which can be accessed at www.drivenbystem.com, or https://www.channelchek.com/channelcast-detail/WET7Ezi6uh.
During the presentation CEO, Adam Berk, provides shareholders with an update on its vertical integration Farm-to-Home™ strategy, as well as the Company’s organic and acquisitive growth plans.
About Stem Holdings
Stem Holdings is a leading omnichannel, vertically-integrated cannabis...
Flora Growth Establishes Long-Term Commitment to Environmental and Economic Sustainability
Written by Customer Service on . Posted in Public Companies.
Flora Growth Corp. Commits to Sustainable and Eco-friendly Practices Throughout Diverse Brand Portfolio Supply Chains
TORONTO, June 29, 2021 (GLOBE NEWSWIRE) — Flora Growth Corp. (NASDAQ: FLGC) (“Flora”, “Flora Growth”, or the “Company”), an all-outdoor cultivator and manufacturer of cannabis-derived products and brands, is pleased to announce that its commitment to environmental sustainability will be represented across the Company’s value chain. Flora Growth’s sustainability initiatives will focus on the modern eco-conscious consumer looking for products made with cruelty-free, natural ingredients in sustainable, biodegradable packaging.
“At Flora, we have made sustainability a pillar of our strategy. We are doing this because consumers are guiding us in this direction, because we’re committed to our planet and our people,” said...
Vision Marine Technologies Fast Tracks Commercialization of our E-Motion™ Electric Powertrain with Up to $1.72 Million (CAD) in Grants Secured from the Government of Quebec
Written by Customer Service on . Posted in Public Companies.
Grants pave the way for Vision Marine to showcase its E-Motion™180 proprietary powertrain technology
MONTREAL, June 29, 2021 (GLOBE NEWSWIRE) — Vision Marine Technologies, Inc. (NASAQ: VMAR) (“Vision Marine” or the “Company”), announced today that the government of Québec through Investissement Québec (IQ), an important catalyst for the Province of Quebec economic development, granted up to $1.72 million (CAD), in the form of a non-refundable contribution to fast track commercialization of the E-Motion™ 180.
“I am honored and proud of what my team has been able to accomplish in such a short period of time. We have been able to demonstrate that our proprietary technology will be a disrupter within the industry. This grant will help to allow us to equip watercraft from major manufacturers to showcase E-Motion’s™ performance and range,”...
Acerus Announces New PBM Contract, Significantly Expanding NATESTO® Insurance Coverage in the United States
Written by Customer Service on . Posted in Public Companies.
NATESTO® Coverage now Includes 85% of Commercial Lives
TORONTO, June 29, 2021 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF), a specialty pharmaceutical company focused on the commercialization of novel prescription products in Men’s Health, today announced that, effective July 1, 2021, an additional leading pharmacy benefit manager (PBM) in the United States has elected to make NATESTO® (testosterone nasal gel) a “Preferred Brand” on its National Preferred Drug List.
“This new formulary placement is another key milestone in Acerus’ commercial efforts in the United States,” said Ed Gudaitis, President and Chief Executive Officer of Acerus. “We now have, without a doubt, best-in-class branded coverage, which we anticipate will lead to enhanced patient access and increased physician prescribing...
InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica, a Commercial Manufacturer of Rare Cannabinoids
Written by Customer Service on . Posted in Mergers And Acquisitions.
VANCOUVER, British Columbia, June 29, 2021 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids, announced that it has entered into a non-binding letter of intent (the “LOI”) to acquire BayMedica Inc. (“BayMedica”), a private company based in Nevada and California that specializes in the manufacture and commercialization of rare cannabinoids.
BayMedica is a revenue-stage biotechnology company leveraging its significant expertise in synthetic biology and pharmaceutical chemistry to develop efficient, scalable, and proprietary manufacturing approaches to produce high quality, regulatory-compliant rare cannabinoids for consumer...
Builders FirstSource to Acquire WTS Paradigm, LLC, a Software Solutions and Services Provider for the Building Products Industry
Written by Customer Service on . Posted in Mergers And Acquisitions.
Transaction accelerates annual billion dollar digital opportunity for Builders FirstSource and advances its strategy to invest in innovative digital solutions that help customers build more efficiently
Paradigm’s technology will drive efficiencies and productivity in the building supply chain, enhancing Builders FirstSource’s portfolio of value-added products and services
Enhanced digital solutions are expected to improve customer satisfaction and drive growth and operating efficiency for Builders FirstSource’s distribution business
DALLAS, June 29, 2021 (GLOBE NEWSWIRE) — Builders FirstSource, Inc. (Nasdaq: BLDR) (“Builders FirstSource”), today announced that it has entered into a definitive agreement to acquire WTS Paradigm, LLC (“Paradigm”), a software solutions and services provider for the building products industry, in a...
Renovacor Announces the Appointments of Joan Lau, Ph.D., and Gregory F. Covino to its Board of Directors
Written by Customer Service on . Posted in Mergers And Acquisitions.
Appointments to be effective upon closing of the previously announced merger between Renovacor and Chardan Healthcare Acquisition 2 Corp.
PHILADELPHIA, June 29, 2021 (GLOBE NEWSWIRE) — Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants, today announced the appointments of Joan Lau, Ph.D., and Gregory F. Covino to its Board of Directors, effective upon the closing of the previously announced merger (the “Merger”) between Renovacor and Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) (“CHAQ”). The closing of the Merger is expected to occur in the third quarter of 2021. Upon the close of the Merger, Mr. Covino will also serve as the Chair of Renovacor’s...
FactSet Reports Solid Results for Third Quarter 2021
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Record Quarterly Revenue Hits $400 Million
NORWALK, Conn., June 29, 2021 (GLOBE NEWSWIRE) — FactSet (“FactSet” or the “Company”) (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading service, today announced results for its third quarter ended May 31, 2021.
Third Quarter Fiscal 2021 HighlightsRevenue increased 6.8%, or $25.5 million, to $399.6 million compared with $374.1 million for the same period in fiscal 2020. The increase is primarily due to higher sales of analytics and content and technology solutions (CTS). Organic revenues grew 5.9% to $397.4 million during the third quarter of fiscal 2021 from the prior year period.Annual Subscription Value (ASV) plus professional services was $1.6 billion at May 31, 2021, compared with $1.5 billion...
Iceland Seafood International hf: Date of transaction 29.6.2021
Written by Customer Service on . Posted in Public Companies.
See attachmentAttachmentVidskipti-fruminnherja-29.6.2021 – MBJ
Zealand Pharma to Present Data on Glepaglutide at the 17th Congress of the Intestinal Rehabilitation and Transplantation Association (CIRTA)
Written by Customer Service on . Posted in Public Companies.
Company announcement – No. 43/ 2021
Zealand Pharma to Present Data on Glepaglutide at the 17th Congress of the Intestinal Rehabilitation and Transplantation Association (CIRTA)Company to present three posters, including two on glepaglutide for the treatment of Short Bowel Syndrome (SBS)
Data demonstrate potential dosing benefits of glepaglutide for patients with SBSCopenhagen, DK and Boston, MA, U.S. June 29, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, today announced it will present three posters at the upcoming 17th Congress of the Intestinal Rehabilitation and Transplantation Association (CIRTA), which is being held both virtually and in Auckland, New Zealand June 30-July 2, 2021. The Company’s...